Feldan Therapeutics Funding: $30M Raised, Series B (2023)
Feldan Therapeutics is a Biotech company based in Quebec City, Country. It has raised $30M in total funding. Latest round: Series B.
Feldan Therapeutics funding overview
Feldan Therapeutics is a Biotech company based in Quebec City, Country. Feldan Therapeutics has raised $30M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in June 2023. The round record for Feldan Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include Investissement Québec, Amgen Ventures, GC Cell, FSIT2, GC Holdings, Genesys Capital and 6 others. 12 distinct backers are named across the disclosed rounds.
Frequently asked about Feldan Therapeutics funding
How much has Feldan Therapeutics raised?
Feldan Therapeutics has raised $30M in total disclosed funding across the rounds on record.
Who has invested in Feldan Therapeutics?
Investissement Québec, Amgen Ventures, GC Cell, FSIT2, GC Holdings, Genesys Capital are named among the investors backing Feldan Therapeutics.
What was the latest Feldan Therapeutics funding round?
The most recent disclosed round is a Series B, announced in June 2023.
Where is Feldan Therapeutics based?
Feldan Therapeutics is based in Quebec City, Country.
What sector does Feldan Therapeutics operate in?
Feldan Therapeutics is tracked under Biotech from Quebec City, Country, with $30M in disclosed funding.
When did Feldan Therapeutics last raise?
The last disclosed Feldan Therapeutics round closed in June 2023 at Series B.
Round data for Feldan Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Quebec City and backer lists below.
